Conducting a COVID-19 drug and vaccine clinical trial
Description
Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.
Resources
| Name |
Format |
Description |
Link |
| Conducting a COVID-19 drug and vaccine clinical trial |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial.html |
| Conducting a COVID-19 drug and vaccine clinical trial |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise.html |